JANSZKY GmbH
VC Fund
Leipzig, Germany
JANSZKY GmbH is a VC fund in Leipzig focused on Information Technology and Consulting. Family Investment Office of Sven Gabor Janszky, one of the leading futurists in Europe.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries JANSZKY GmbH invests in
Stages JANSZKY GmbH invests in
Countries JANSZKY GmbH invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $9k–$4.6M
- Pre-Seed
- $180k–$1.4M
Investment Focus
Industry
- Information Technology 3 (17%)
- Consulting 2 (11%)
- Biotechnology 2 (11%)
- AgTech 1 (6%)
- Computer 1 (6%)
Stage
- Seed 10 (56%)
- Pre-Seed 3 (17%)
- Series A 2 (11%)
- Angel 1 (6%)
Country
- Germany 6 (33%)
- Israel 1 (6%)
- United States 1 (6%)
- United Kingdom 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 21 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
With our KI™ technology, and our partners, we will enable growers to respond to weather changes and avoid yield loss by timely activation of the relevant traits, such as drought tolerance trait, or cold tolerance trait, in the crops they are growing, when and where they need it. Our current focus is to tackle one of the biggest challenges thatthe world faces today - reduce yield loss caused by drought | $1M / Seed / Jan 09, 2024 | |
|
|
Future of Selfie | Seed / Jan 03, 2022 | |
|
|
Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | Series A / Jan 03, 2022 | |
|
|
Future of Selfie | Pre-Seed / Jan 03, 2022 | |
|
|
X-Therma is a biotechnology firm that is developing a convergent biopreservation platform to advance regenerative medicine. Using convergent biomimetic nanotechnology, the company is addressing unmet legacy needs in biological product storage. This solution can improve critical biomanufacturing processes, safer transport, and long-term biobankingfor advanced cell therapies, IVF, organ transplants, and other rapidly growing regenerative medicine areas. | $13M / Series A / Dec 22, 2021 | |
|
|
With our KI™ technology, and our partners, we will enable growers to respond to weather changes and avoid yield loss by timely activation of the relevant traits, such as drought tolerance trait, or cold tolerance trait, in the crops they are growing, when and where they need it. Our current focus is to tackle one of the biggest challenges thatthe world faces today - reduce yield loss caused by drought | Seed / Dec 10, 2021 | |
|
|
With our KI™ technology, and our partners, we will enable growers to respond to weather changes and avoid yield loss by timely activation of the relevant traits, such as drought tolerance trait, or cold tolerance trait, in the crops they are growing, when and where they need it. Our current focus is to tackle one of the biggest challenges thatthe world faces today - reduce yield loss caused by drought | $1.4M / Pre-Seed / Dec 10, 2021 | |
|
|
The science based Future Coaching and Life Coaching program of Europes leading future coach. | $60.5K / Seed / Jan 06, 2021 | |
|
2b AHEAD Ventures Fund
|
The first self controlled investment arm of 2b AHEAD Ventures company builder. The fonds gives German top managers the chance to invest in deeptech startups founded by 2b AHEAD Ventures company builder. No other startups will be served. | $238.5K / Seed / Sep 01, 2020 | |
|
|
Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | $4.5M / Seed / Jun 14, 2020 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does JANSZKY GmbH invest in?
JANSZKY GmbH invests primarily in Information Technology, Consulting and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 18 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is JANSZKY GmbH's check size?
JANSZKY GmbH typically joins rounds of $9k–$4.6M at Seed and $180k–$1.4M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds JANSZKY GmbH participates in.
How do I contact JANSZKY GmbH?
Public channels for JANSZKY GmbH include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at JANSZKY GmbH?
The team at JANSZKY GmbH includes Sven Gabor Janszky (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!